{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:31:56Z","timestamp":1781620316899,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2022CDJYGRH-001"],"award-info":[{"award-number":["2022CDJYGRH-001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99888-8","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:06:00Z","timestamp":1746594360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum \u03b22-microglobulin level is associated with the survival of HIV-associated diffuse large B-cell lymphoma: a retrospective study from China"],"prefix":"10.1038","volume":"15","author":[{"given":"Xinyi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zailin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"99888_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/01.cco.0000432525.70099.a4","volume":"25","author":"E Cesarman","year":"2013","unstructured":"Cesarman, E. Pathology of lymphoma in HIV. Curr. Opin. Oncol. 25:487\u2013494. (2013). https:\/\/doi.org\/10.1097\/01.cco.0000432525.70099.a4","journal-title":"Curr. Opin. Oncol."},{"key":"99888_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood.2020005469","volume":"139","author":"A Carbone","year":"2022","unstructured":"Carbone, A., Vaccher, E. & Gloghini, A. Hematologic cancers in individuals infected by HIV. Blood 139, 995\u20131012. https:\/\/doi.org\/10.1182\/blood.2020005469 (2022).","journal-title":"Blood"},{"key":"99888_CR3","doi-asserted-by":"publisher","unstructured":"Huguet, M., Navarro, J. T., Molto, J., Ribera, J. M. & Tapia, G. Diffuse large B-Cell lymphoma in the HIV setting. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15123191 (2023).","DOI":"10.3390\/cancers15123191"},{"key":"99888_CR4","doi-asserted-by":"publisher","unstructured":"Lurain, K. et al. Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin\u2019s lymphoma. J. Immunother Cancer 9. https:\/\/doi.org\/10.1136\/jitc-2020-002097 (2021).","DOI":"10.1136\/jitc-2020-002097"},{"key":"99888_CR5","doi-asserted-by":"publisher","first-page":"675353","DOI":"10.3389\/fonc.2021.675353","volume":"11","author":"PS de Carvalho","year":"2021","unstructured":"de Carvalho, P. S., Leal, F. E. & Soares, M. A. Clinical and molecular properties of human immunodeficiency virus-related diffuse large B-Cell lymphoma. Front. Oncol. 11, 675353. https:\/\/doi.org\/10.3389\/fonc.2021.675353 (2021).","journal-title":"Front. Oncol."},{"key":"99888_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/QAD.0000000000000624","volume":"29","author":"MJ Baptista","year":"2015","unstructured":"Baptista, M. J. et al. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era. Aids 29, 811\u2013818. https:\/\/doi.org\/10.1097\/QAD.0000000000000624 (2015).","journal-title":"Aids"},{"key":"99888_CR7","doi-asserted-by":"publisher","first-page":"e2019004","DOI":"10.4084\/MJHID.2019.004","volume":"11","author":"A Re","year":"2019","unstructured":"Re, A., Cattaneo, C. & Rossi, G. Hiv and lymphoma: From epidemiology to clinical management. Mediterr. J. Hematol. Infect. Dis. 11, e2019004. https:\/\/doi.org\/10.4084\/MJHID.2019.004 (2019).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"99888_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13104-020-05135-w","volume":"13","author":"F Nosratzehi","year":"2020","unstructured":"Nosratzehi, F., Nosratzehi, T., Alijani, E. & Rad, S. S. Salivary beta2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma. BMC Res. Notes. 13, 294. https:\/\/doi.org\/10.1186\/s13104-020-05135-w (2020).","journal-title":"BMC Res. Notes"},{"key":"99888_CR9","doi-asserted-by":"publisher","first-page":"944722","DOI":"10.3389\/fonc.2022.944722","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang, C., Wang, Z., Yao, T., Zhou, J. & Wang, Z. The immune-related role of beta-2-microglobulin in melanoma. Front. Oncol. 12, 944722. https:\/\/doi.org\/10.3389\/fonc.2022.944722 (2022).","journal-title":"Front. Oncol."},{"key":"99888_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0165-2478(92)90097-8","volume":"33","author":"L Paczek","year":"1992","unstructured":"Paczek, L., Czarkowska, B., Schaefer, L., Schaefer, R. M. & Heidland, A. Effect of beta 2-microglobulin on Immunoglobulin production. Immunol. Lett. 33, 87\u201391. https:\/\/doi.org\/10.1016\/0165-2478(92)90097-8 (1992).","journal-title":"Immunol. Lett."},{"key":"99888_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/18715206113139990092","volume":"14","author":"T Nomura","year":"2014","unstructured":"Nomura, T. et al. beta2-Microglobulin-mediated signaling as a target for cancer therapy. Anticancer Agents Med. Chem. 14, 343\u2013352. https:\/\/doi.org\/10.2174\/18715206113139990092 (2014).","journal-title":"Anticancer Agents Med. Chem."},{"key":"99888_CR12","doi-asserted-by":"publisher","first-page":"12907","DOI":"10.1038\/s41598-018-31212-z","volume":"8","author":"Y Shang","year":"2018","unstructured":"Shang, Y., Fu, X., Chang, Y., Li, Y. & Zhang, M. B2 microglobulin is a novel prognostic marker of angioimmunoblastic T-cell lymphoma. Sci. Rep. 8, 12907. https:\/\/doi.org\/10.1038\/s41598-018-31212-z (2018).","journal-title":"Sci. Rep."},{"key":"99888_CR13","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00277-012-1434-1","volume":"91","author":"ZM Li","year":"2012","unstructured":"Li, Z. M. et al. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK\/T-cell lymphoma. Ann. Hematol. 91, 1265\u20131270. https:\/\/doi.org\/10.1007\/s00277-012-1434-1 (2012).","journal-title":"Ann. Hematol."},{"key":"99888_CR14","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical hodgkin lymphoma treated in the modern era. Oncotarget 7 72219-72228. https:\/\/doi.org\/10.18632\/oncotarget.12663 (2016).","DOI":"10.18632\/oncotarget.12663"},{"key":"99888_CR15","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s10238-023-01061-w","volume":"23","author":"NC Chen","year":"2023","unstructured":"Chen, N. C. et al. Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma. Clin. Exp. Med. 23, 3759\u20133766. https:\/\/doi.org\/10.1007\/s10238-023-01061-w (2023).","journal-title":"Clin. Exp. Med."},{"key":"99888_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hon.2312","volume":"35","author":"Y Kanemasa","year":"2017","unstructured":"Kanemasa, Y. et al. Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma. Hematol. Oncol. 35, 440\u2013446. https:\/\/doi.org\/10.1002\/hon.2312 (2017).","journal-title":"Hematol. Oncol."},{"key":"99888_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1423-0410.1980.tb04500.x","volume":"38","author":"GM Bernier","year":"1980","unstructured":"Bernier, G. M. beta 2-Microglobulin: Structure, function and significance. Vox Sang. 38, 323\u2013327. https:\/\/doi.org\/10.1111\/j.1423-0410.1980.tb04500.x (1980).","journal-title":"Vox Sang"},{"key":"99888_CR18","doi-asserted-by":"publisher","first-page":"b396","DOI":"10.1093\/ofid\/ofab396","volume":"8","author":"EA Hixson","year":"2021","unstructured":"Hixson, E. A., Borker, P. V., Jackson, E. K. & Macatangay, B. J. The adenosine pathway and human immunodeficiency virus-associated inflammation. Open. Forum Infect. Dis. 8, b396. https:\/\/doi.org\/10.1093\/ofid\/ofab396 (2021).","journal-title":"Open. Forum Infect. Dis."},{"key":"99888_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00262-020-02545-4","volume":"69","author":"KH Kim","year":"2020","unstructured":"Kim, K. H., Sim, N. S., Chang, J. S. & Kim, Y. B. Tumor immune microenvironment in cancer patients with leukocytosis. Cancer Immunol. Immunother. 69, 1265\u20131277. https:\/\/doi.org\/10.1007\/s00262-020-02545-4 (2020).","journal-title":"Cancer Immunol. Immunother"},{"key":"99888_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.7314\/apjcp.2013.14.2.929","volume":"14","author":"D Zhou","year":"2013","unstructured":"Zhou, D. et al. Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: A retrospective analysis of 227 cases. Asian Pac. J. Cancer Prev. 14, 929\u2013934. https:\/\/doi.org\/10.7314\/apjcp.2013.14.2.929 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"99888_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/COH.0000000000000240","volume":"11","author":"V Appay","year":"2016","unstructured":"Appay, V. & Kelleher, A. D. Immune activation and immune aging in HIV infection. Curr. Opin. Hiv Aids 11, 242\u2013249. https:\/\/doi.org\/10.1097\/COH.0000000000000240 (2016).","journal-title":"Curr. Opin. Hiv Aids"},{"key":"99888_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/QAD.0000000000003549","volume":"37","author":"JC Vargas","year":"2023","unstructured":"Vargas, J. C. et al. Factors associated with survival in patients with lymphoma and HIV. Aids 37, 1217\u20131226 (2023). https:\/\/doi.org\/10.1097\/QAD.0000000000003549","journal-title":"Aids"},{"key":"99888_CR23","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-10-3382","volume":"71","author":"S Josson","year":"2011","unstructured":"Josson, S. et al. beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res. 71, 2600\u20132610. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3382 (2011).","journal-title":"Cancer Res."},{"key":"99888_CR24","first-page":"3755","volume":"89","author":"G Gaidano","year":"1997","unstructured":"Gaidano, G. et al. Frequent mutation of the 5\u2019 noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin\u2019s lymphomas. Blood 89, 3755\u20133762 (1997).","journal-title":"Blood"},{"key":"99888_CR25","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1002\/ijc.32381","volume":"145","author":"A Maguire","year":"2019","unstructured":"Maguire, A. et al. Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature. Int. J. Cancer. 145, 3078\u20133088. https:\/\/doi.org\/10.1002\/ijc.32381 (2019).","journal-title":"Int. J. Cancer"},{"key":"99888_CR26","doi-asserted-by":"publisher","first-page":"e17481","DOI":"10.1016\/j.heliyon.2023.e17481","volume":"9","author":"VR Arenas","year":"2023","unstructured":"Arenas, V. R., Rugeles, M. T., Perdomo-Celis, F. & Taborda, N. Recent advances in CD8(+) T cell-based immune therapies for HIV cure. Heliyon 9, e17481. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17481 (2023).","journal-title":"Heliyon"},{"key":"99888_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5045\/br.2022.2021145","volume":"57","author":"AM Greenbaum","year":"2022","unstructured":"Greenbaum, A. M., Fromm, J. R., Gopal, A. K. & Houghton, A. M. Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8(+) T-cells despite immune checkpoint signaling. Blood Res. 57, 117\u2013128. https:\/\/doi.org\/10.5045\/br.2022.2021145 (2022).","journal-title":"Blood Res."},{"key":"99888_CR28","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1080\/10428194.2019.1617861","volume":"60","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. Peripheral blood lymphocyte subsets of newly diagnosed DLBCL patients and their dynamic changes with rituximab based immunochemotherapy. Leuk. Lymphoma 60, 2909\u20132916. https:\/\/doi.org\/10.1080\/10428194.2019.1617861 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"99888_CR29","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1111\/jcmm.17534","volume":"26","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Clinical characteristics and outcomes of newly diagnosed patients with HIV-associated aggressive B-cell NHL in China. J. Cell. Mol. Med. 26, 5067\u20135077. https:\/\/doi.org\/10.1111\/jcmm.17534 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"99888_CR30","doi-asserted-by":"publisher","first-page":"12470","DOI":"10.1002\/cam4.5957","volume":"12","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era. Cancer Med. 12, 12470\u201312481. https:\/\/doi.org\/10.1002\/cam4.5957 (2023).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99888-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99888-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99888-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:06:01Z","timestamp":1746594361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99888-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99888"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99888-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Affiliated Chongqing University Cancer Hospital Ethics Committee (approval no. CZLS2023085-A-100).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, please see: .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements"}}],"article-number":"15870"}}